Patent Assignment
Reel/Frame 075015/0854
Security Interest
Recorded: 2026-03-03
Pages: 42
Assignor
SCHOLAR ROCK, INC.
Executed: 2026-02-27
Assignee
LSI FINANCING LLC, AS ADMINISTRATIVE AGENT
C/O BLUE OWL CAPITAL CORPORATION , 399 PARK AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties
(74)
Compositions and Methods for Growth Factor Modulation
Compositions and Methods for Growth Factor Modulation
Application:
19/335,639 →
Publication:
US 2026/0109757
TGFBETA1-Binding Immunoglobulins and Use Thereof
Application:
18/193,979 →
Publication:
US 2023/0348583
Isoform-Specific, Context-Permissive TGFB1 Inhibitors and Use Thereof
Application:
18/363,435 →
Publication:
US 2024/0016928
Rgmc-Selective Inhibitors and Use Thereof
Application:
19/178,027 →
Publication:
US 2025/0304669
Methods of Treating Myopathies with Anti-Pro/Latent Myostatin Antibodies
Application:
18/431,294 →
Publication:
US 2024/0374718
Method of Making Anti-Pro/Latent Myostatin Antibodies
Methods for Inhibiting Myostatin Activation by Administering Anti-Pro/Latent Myostatin Antibodies
Application:
18/646,693 →
Publication:
US 2024/0391989
Sheet Processing Apparatus and Image Forming System Including Sheet Processing Apparatus
Application:
19/247,341 →
Publication:
US 2026/0003312
Use of Myostatin Inhibitors and Combination Therapies
Application:
17/248,700 →
Publication:
US 2021/0283166
Methods for Treating Metabolic Diseases by Inhibiting Myostatin Activation
Application:
19/083,831 →
Publication:
US 2026/0035447
Tgf-Beta Inhibitors and Use Thereof
Application:
17/758,524 →
Publication:
US 2023/0050148
Use of Anti-Pro/Latent Myostatin Antibody for Treating Spinal Muscular Atrophy
Application:
18/250,489 →
Publication:
US 2024/0002490
Tgf-Beta Inhibitors and Use Thereof
Application:
18/283,904 →
Publication:
US 2025/0282857
A Myostatin Pathway Inhibitor in Combination with a Glp-1 Pathway Activator for Use in Treating Metabolic Disorders
Application:
18/572,397 →
Publication:
US 2024/0368262
Use of Myostatin Inhibitor for Treating Spinal Muscular Atrophy
Application:
18/862,079 →
Publication:
US 2025/0326827
Selective and Potent Inhibitory Antibodies of Myostatin Activation
Application:
19/212,099 →
Publication:
US 2026/0035448
Selective and Potent Inhibitory Antibodies of Myostatin Activation
Application:
19/141,807 →
Tgf-Beta Inhibitors for Use for Treating Resistant or Unresponsive Cancer in Patients
Application:
19/162,789 →
Ltbp Complex-Specific Inhibitors of Tgfb and Uses Thereof
Application:
18/941,156 →
Publication:
US 2025/0179164
HIGH-AFFINITY, ISOFORM-SELECTIVE TGFß1 INHIBITORS AND USE THEREOF
Application:
19/045,513 →
Publication:
US 2025/0257125
Isoform-Selective TGFB1 Inhibitors and Use Thereof
Application:
18/887,382 →
Publication:
US 2025/0215072
Tgfb Inhibitors and Use Thereof
Application:
17/791,859 →
Publication:
US 2023/0057012
Ltbp Complex-Specific Inhibitors of TGFB1 and Uses Thereof
Application:
18/578,341 →
Publication:
US 2024/0301073
Compositions and Methods for Growth Factor Modulation
Compositions and Methods for Growth Factor Modulation
Compositions and Methods for Growth Factor Modulation
Compositions and Methods for Growth Factor Modulation
Compositions and Methods for Growth Factor Modulation
Compositions and Methods for Growth Factor Modulation
Compositions and Methods for Growth Factor Modulation
Compositions and Methods for Growth Factor Modulation
Compositions and Methods for Growth Factor Modulation
TGFBETA1-Binding Immunoglobulins and Use Thereof
Tgfbeta Antibodies, Methods and Uses
Rgmc-Selective Inhibitors and Use Thereof
Anti-Pro/Latent-Myostatin Antibodies and Uses Thereof
Methods for Making and Using Anti-Myostatin Antibodies
Compositions for Making and Using Anti-Myostatin Antibodies
Anti-Pro/Latent-Myostatin Antibodies and Uses Thereof
Methods for Using Anti-Myostatin Antibodies
Methods for Inhibiting Myostatin Activation by Administering Anti-Pro/Latent Myostatin Antibodies
Methods for Inhibiting Myostatin Activation by Administering Anti-Pro/Latent Myostatin Antibodies
Methods for Altering Body Composition by Administering Anti-Pro/Latent Myostatin Antibodies
Use of Myostatin Inhibitors and Combination Therapies
Compositions and Methods for Making and Using Anti-Myostatin Antibodies
Selective and Potent Inhibitory Antibodies of Myostatin Activation
Ltbp Complex-Specific Inhibitors of Tgf-Beta 1 and Uses Thereof
Ltbp Complex-Specific Inhibitors of Tgfb and Uses Thereof
Ltbp Complex-Specific Inhibitors of Tgfb and Uses Thereof
Ltbp Complex-Specific Inhibitors of Tgfb and Uses Thereof
Methods of Screening for High-Affinity, Isoform- Selective TGFB1 Inhibitors
Isoform-Selective TGFB1 Inhibitors and Use Thereof
Isoform-Selective TGFB1 Inhibitors and Use Thereof
Compositions and Methods for Growth Factor Modulation
PCT:
PCT/US2014/036933 ↗
TGFB1-Binding Immunoglobulins and Use Thereof
PCT:
PCT/US2017/021972 ↗
Tgfb Antibodies, Methods, and Uses
PCT:
PCT/US2017/042162 ↗
LRRC33 Inhibitors and Use Thereof
PCT:
PCT/US2018/031759 ↗
Isoform-Specific, Context-Permissive TGFB1 Inhibitors and Use Thereof
PCT:
PCT/US2018/012601 ↗
Rgmc-Selective Inhibitors and Use Thereof
PCT:
PCT/US2019/057687 ↗
Anti-Pro/Latent-Myostatin Antibodies and Uses Thereof
PCT:
PCT/US2015/059468 ↗
Anti-Pro/Latent-Myostatin Antibodies and Uses Thereof
PCT:
PCT/US2016/052014 ↗
Anti-Pro/Latent Myostatin Antibodies and Methods of Use Thereof
PCT:
PCT/US2017/012606 ↗
Use of Myostatin Inhibitors and Combination Therapies
PCT:
PCT/US2017/037332 ↗
Methods for Treating Metabolic Diseases by Inhibiting Myostatin Activation
PCT:
PCT/US2018/012686 ↗
Tgf-Beta Inhibitors and Use Thereof
PCT:
PCT/US2021/012969 ↗
Use of Anti-Pro/Latent Myostatin Antibody for Treating Spinal Muscular Atrophy
PCT:
PCT/US2021/056517 ↗
Tgf-Beta Inhibitors and Use Thereof
PCT:
PCT/US2022/022063 ↗
Therapies for Weight Management and Related Metabolic Conditions
PCT:
PCT/US2022/034588 ↗
Selective and Potent Inhibitors of Myostatin Activation
PCT:
PCT/US2023/085574 ↗
Tgf-Beta Inhibitors and Therapeutic Use Thereof
PCT:
PCT/US2024/018970 ↗
Myostatin-Selective Inhibitors for Treating Metabolic Disorders
PCT:
PCT/US2025/030263 ↗
Enterotoxigenic Escherichia Coli Multi-Epitope Fusion Antigen Proteins and Use
PCT:
PCT/US2025/040343 ↗
Use of Myostatin Inhibitor for Treating Spinal Muscular Atrophy
PCT:
PCT/US2023/020843 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 3, 2015
From: SCHURPF, THOMAS; MAHANTHAPPA, NAGESH K.; STRAUB, MICHELLE MARIE
To: SCHOLAR ROCK, INC.
Reel/Frame 037202/0290 →
Assignment of Assignor's Interest
Jan 10, 2020
From: SCHURPF, THOMAS; MAHANTHAPPA, NAGESH K.; STRAUB, MICHELLE MARIE
To: SCHOLAR ROCK, INC.
Reel/Frame 051476/0551 →
Assignment of Assignor's Interest
Mar 15, 2023
From: MARTIN, CONSTANCE; LEE-HOEFLICH, SI TUEN; KALRA, ASHISH; SCHURPF, THOMAS
To: SCHOLAR ROCK, INC.
Reel/Frame 062990/0298 →
Assignment of Assignor's Interest
May 26, 2023
From: WAWERSIK, STEFAN; SCHURPF, THOMAS; CHAPRON, CHRISTOPHER; KUMAR, SANDEEP
To: SCHOLAR ROCK, INC.
Reel/Frame 063771/0075 →
Assignment of Assignor's Interest
Dec 9, 2024
From: CARVEN, GREGORY J.; STRAUB, MICHELLE; DONOVAN, ADRIANA; TURNER, KATHERINE JANE
To: SCHOLAR ROCK, INC.
Reel/Frame 069525/0715 →
Change of Address of Assignee
Dec 9, 2024
From: SCHOLAR ROCK, INC.
To: SCHOLAR ROCK, INC.
Reel/Frame 069548/0303 →
Assignment of Assignor's Interest
Jan 30, 2025
From: LONG, KIMBERLY; DONOVAN, ADRIANA; CHYUNG, YUNG; STRAUB, MICHELLE
To: SCHOLAR ROCK, INC.
Reel/Frame 070056/0769 →
Statement of Change of Address of Assignee
Mar 17, 2025
From: SCHOLAR ROCK, INC.
To: SCHOLAR ROCK, INC.
Reel/Frame 070529/0204 →
Assignment of Assignor's Interest
Mar 19, 2025
From: DONOVAN, ADRIANA; STRAUB, MICHELLE; WAWERSIK, STEFAN; CHYUNG, YUNG
To: SCHOLAR ROCK, INC.
Reel/Frame 070565/0802 →
Assignment of Assignor's Interest
Apr 17, 2025
From: DATTA, ABHISHEK; CAPILI, ALLAN; SCHURPF, THOMAS; MARTIN, CONSTANCE
To: SCHOLAR ROCK, INC.
Reel/Frame 070871/0511 →
Assignment of Assignor's Interest
Jun 24, 2025
From: KOZAKI, ERIKO
To: KONICA MINOLTA, INC.
Reel/Frame 071504/0040 →
Change of Assignee Address
Sep 16, 2025
From: SCHOLAR ROCK, INC.
To: SCHOLAR ROCK, INC.
Reel/Frame 072878/0561 →
Assignment of Assignor's Interest
Sep 17, 2025
From: STRAUB, MICHELLE; LEE, DONG YUN; MCCONAUGHY, WILLIAM K.; TURNER, KATHERINE JANE
To: SCHOLAR ROCK, INC.
Reel/Frame 072286/0487 →
Change of Assignee Address
Oct 31, 2025
From: SCHOLAR ROCK, INC.
To: SCHOLAR ROCK, INC.
Reel/Frame 073225/0055 →
Assignment of Assignor's Interest
Nov 5, 2025
From: CHAPRON, CHRISTOPHER; STREICH, FREDERICK C., JR.; COTE, SHAUN M.; DANEHY, FRANCIS, JR.
To: SCHOLAR ROCK, INC.
Reel/Frame 072798/0894 →
Assignment of Assignor's Interest
Nov 5, 2025
From: CANONICO, KALEIGH; FULHAM, MELISSA
To: SCHOLAR ROCK, INC.
Reel/Frame 072798/0915 →
Assignment of Assignor's Interest
Dec 5, 2025
From: DONOVAN, ADRIANA; STRAUB, MICHELLE; WAWERSIK, STEFAN
To: SCHOLAR ROCK, INC.
Reel/Frame 073129/0671 →
Assignment of Assignor's Interest
Feb 23, 2026
From: SCHUTZ, KEVIN
To: ADIMAB, LLC
Reel/Frame 073865/0392 →
Assignment of Assignor's Interest
Feb 24, 2026
From: BUKOWSKI, JOHN
To: ADIMAB, LLC
Reel/Frame 073880/0306 →
Assignment of Assignor's Interest
Feb 24, 2026
From: JACKSON, JUSTIN W.
To: SCHOLAR ROCK, INC.
Reel/Frame 073876/0762 →
Assignment of Assignor's Interest
Feb 24, 2026
From: NICHOLLS, SAMANTHA; DONOVAN, ADRIANA; MCDONALD, MEGHAN; DATTA, ABHISHEK
To: SCHOLAR ROCK, INC.
Reel/Frame 073876/0835 →
Assignment of Assignor's Interest
Feb 24, 2026
From: DAGBAY, KEVIN B.
To: SCHOLAR ROCK, INC.
Reel/Frame 073876/0937 →
Assignment of Assignor's Interest
Feb 24, 2026
From: SCHOLAR ROCK, INC.
To: ADIMAB, LLC
Reel/Frame 073876/0970 →
Assignment of Assignor's Interest
Feb 25, 2026
From: ADIMAB, LLC
To: SCHOLAR ROCK, INC.
Reel/Frame 073887/0420 →
Assignment of Assignor's Interest
Feb 25, 2026
From: NICHOLLS, SAMANTHA; DONOVAN, ADRIANA; MCDONALD, MEGHAN; DATTA, ABHISHEK
To: SCHOLAR ROCK, INC.
Reel/Frame 073887/0480 →